Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 24 04:00PM ET
0.3190
Dollar change
-0.1265
Percentage change
-28.40
%
Index- P/E- EPS (ttm)-599.49 Insider Own1.34% Shs Outstand17.61M Perf Week-29.87%
Market Cap5.62M Forward P/E- EPS next Y-1.56 Insider Trans0.00% Shs Float17.37M Perf Month-50.16%
Income-21.13M PEG- EPS next Q-0.29 Inst Own0.01% Short Float6.75% Perf Quarter-95.46%
Sales0.00M P/S- EPS this Y98.73% Inst Trans-16.93% Short Ratio0.26 Perf Half Y-97.23%
Book/sh-23.28 P/B- EPS next Y40.00% ROA-100.46% Short Interest1.17M Perf Year-99.78%
Cash/sh0.02 P/C18.12 EPS next 5Y- ROE-20995.16% 52W Range0.39 - 269.80 Perf YTD-97.11%
Dividend Est.- P/FCF- EPS past 5Y57.56% ROI- 52W High-99.88% Beta0.40
Dividend TTM- Quick Ratio0.13 Sales past 5Y-25.00% Gross Margin- 52W Low-17.59% ATR (14)0.11
Dividend Ex-Date- Current Ratio0.13 EPS Y/Y TTM98.78% Oper. Margin0.00% RSI (14)17.13 Volatility11.28% 10.53%
Employees6 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price8.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q99.34% Payout- Rel Volume1.06 Prev Close0.45
Sales Surprise- EPS Surprise-1157.95% Sales Q/Q- EarningsMay 14 AMC Avg Volume4.44M Price0.32
SMA20-39.82% SMA50-65.20% SMA200-96.16% Trades Volume4,705,773 Change-28.40%
Today 07:16AM
May-20-24 08:00AM
May-15-24 06:53AM
May-14-24 04:01PM
May-07-24 12:00PM
09:30AM Loading…
09:30AM
May-06-24 10:21AM
08:00AM
May-02-24 11:27AM
11:13AM
08:00AM
Apr-29-24 07:00AM
Apr-17-24 09:10AM
Apr-12-24 08:18AM
Apr-04-24 09:15AM
08:30AM Loading…
Mar-27-24 08:30AM
Mar-25-24 07:30AM
Mar-08-24 07:15AM
Feb-28-24 06:00AM
Dec-12-23 06:00AM
Dec-05-23 10:07AM
07:30AM
Oct-02-23 07:00AM
Sep-14-23 09:25AM
Aug-30-23 04:05PM
Jul-31-23 06:00AM
Jul-24-23 06:00AM
Jul-12-23 04:00AM
Jul-06-23 06:00AM
Jul-05-23 09:45AM
11:55AM Loading…
Jun-28-23 11:55AM
Jun-27-23 06:16PM
Jun-20-23 04:05PM
May-30-23 06:00AM
Apr-27-23 09:00AM
Apr-19-23 09:18AM
Apr-17-23 09:00AM
05:24AM
Apr-16-23 06:30AM
Apr-11-23 07:00AM
Mar-31-23 05:15AM
Mar-28-23 09:12AM
06:00AM
Mar-24-23 06:00AM
Mar-20-23 06:00AM
Jan-31-23 07:54AM
Jan-20-23 04:01PM
Dec-01-22 04:25PM
Nov-15-22 04:01PM
Nov-07-22 06:15PM
Oct-18-22 08:00AM
Oct-11-22 04:05PM
Sep-26-22 06:00AM
Sep-16-22 06:00AM
Sep-13-22 05:20AM
Sep-12-22 04:10PM
Aug-26-22 04:30PM
Aug-02-22 06:00AM
Jul-11-22 07:00AM
Jun-29-22 04:01PM
Jun-15-22 09:25AM
May-27-22 05:37PM
May-18-22 05:30PM
May-16-22 07:40PM
Apr-22-22 05:00PM
Mar-15-22 08:32AM
Feb-18-22 04:15PM
Jan-21-22 02:30AM
Jan-03-22 08:00AM
Dec-22-21 08:00AM
Dec-21-21 08:00AM
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.